Literature DB >> 20504924

Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice.

Michelle D Tate1, Danielle L Pickett, Nico van Rooijen, Andrew G Brooks, Patrick C Reading.   

Abstract

Airway macrophages provide a first line of host defense against a range of airborne pathogens, including influenza virus. In this study, we show that influenza viruses differ markedly in their abilities to infect murine macrophages in vitro and that infection of macrophages is nonproductive and no infectious virus is released. Virus strain BJx109 (H3N2) infected macrophages with high efficiency and was associated with mild disease following intranasal infection of mice. In contrast, virus strain PR8 (H1N1) was poor in its ability to infect macrophages and highly virulent for mice. Depletion of airway macrophages by clodronate-loaded liposomes led to the development of severe viral pneumonia in BJx109-infected mice but did not modulate disease severity in PR8-infected mice. The severe disease observed in macrophage-depleted mice infected with BJx109 was associated with exacerbated virus replication in the airways, leading to severe airway inflammation, pulmonary edema, and vascular leakage, indicative of lung injury. Thymic atrophy, lymphopenia, and dysregulated cytokine and chemokine production were additional systemic manifestations associated with severe disease. Thus, airway macrophages play a critical role in limiting lung injury and associated disease caused by BJx109. Furthermore, the inability of PR8 to infect airway macrophages may be a critical factor contributing to its virulence for mice.

Entities:  

Mesh:

Year:  2010        PMID: 20504924      PMCID: PMC2897615          DOI: 10.1128/JVI.00291-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

Review 1.  Mannose receptor.

Authors:  S E Pontow; V Kery; P D Stahl
Journal:  Int Rev Cytol       Date:  1992

2.  Immune impairment of alveolar macrophage phagocytosis during influenza virus pneumonia.

Authors:  G J Jakab
Journal:  Am Rev Respir Dis       Date:  1982-11

3.  Experimental influenza A virus myocarditis in mice. Light and electron microscopic, virologic, and hemodynamic study.

Authors:  M Kotaka; Y Kitaura; H Deguchi; K Kawamura
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

Review 4.  Influenza: pathogenesis and host defense.

Authors:  B S Bender; P A Small
Journal:  Semin Respir Infect       Date:  1992-03

5.  Fatal influenza A myocarditis with isolation of virus from the myocardium.

Authors:  E Engblom; T O Ekfors; O H Meurman; A Toivanen; J Nikoskelainen
Journal:  Acta Med Scand       Date:  1983

6.  Protective mechanisms against pulmonary infection with influenza virus. I. Relative contribution of polymorphonuclear leukocytes and of alveolar macrophages to protection during the early phase of intranasal infection.

Authors:  H Fujisawa; S Tsuru; M Taniguchi; Y Zinnaka; K Nomoto
Journal:  J Gen Virol       Date:  1987-02       Impact factor: 3.891

7.  Gene composition of high-yielding influenza vaccine strains obtained by recombination.

Authors:  M Baez; P Palese; E D Kilbourne
Journal:  J Infect Dis       Date:  1980-03       Impact factor: 5.226

8.  Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity.

Authors:  G N Rogers; J C Paulson; R S Daniels; J J Skehel; I A Wilson; D C Wiley
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

9.  Interaction of influenza virus with mouse macrophages.

Authors:  B Rodgers; C A Mims
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

10.  Experimental myocarditis induced in mice by infection with influenza A2 virus.

Authors:  M Sakamoto; F Suzuki; S Arai; T Takishima; N Ishida
Journal:  Microbiol Immunol       Date:  1981       Impact factor: 1.955

View more
  113 in total

1.  MyD88 mediates in vivo effector functions of alveolar macrophages in acute lung inflammatory responses to carbon nanotube exposure.

Authors:  Evan A Frank; M Eileen Birch; Jagjit S Yadav
Journal:  Toxicol Appl Pharmacol       Date:  2015-08-10       Impact factor: 4.219

2.  Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam₂Cys.

Authors:  Edin J Mifsud; Amabel C L Tan; Patrick C Reading; David C Jackson
Journal:  Immunol Cell Biol       Date:  2015-08-14       Impact factor: 5.126

Review 3.  The development and function of lung-resident macrophages and dendritic cells.

Authors:  Manfred Kopf; Christoph Schneider; Samuel P Nobs
Journal:  Nat Immunol       Date:  2015-01       Impact factor: 25.606

4.  AIM2 Inflammasome Is Critical for Influenza-Induced Lung Injury and Mortality.

Authors:  Hongbo Zhang; Jiadi Luo; John F Alcorn; Kong Chen; Songqing Fan; Joseph Pilewski; Aizhong Liu; Wei Chen; Jay K Kolls; Jieru Wang
Journal:  J Immunol       Date:  2017-04-19       Impact factor: 5.422

5.  Pneumolysin expression by streptococcus pneumoniae protects colonized mice from influenza virus-induced disease.

Authors:  Amaya I Wolf; Maura C Strauman; Krystyna Mozdzanowska; Katie L Williams; Lisa C Osborne; Hao Shen; Qin Liu; David Garlick; David Artis; Scott E Hensley; Andrew J Caton; Jeffrey N Weiser; Jan Erikson
Journal:  Virology       Date:  2014-07-05       Impact factor: 3.616

6.  Strain-dependent effects of PB1-F2 of triple-reassortant H3N2 influenza viruses in swine.

Authors:  Lindomar Pena; Amy L Vincent; Crystal L Loving; Jamie N Henningson; Kelly M Lager; Weizhong Li; Daniel R Perez
Journal:  J Gen Virol       Date:  2012-07-18       Impact factor: 3.891

7.  Widespread Virus Replication in Alveoli Drives Acute Respiratory Distress Syndrome in Aerosolized H5N1 Influenza Infection of Macaques.

Authors:  Elizabeth R Wonderlich; Zachary D Swan; Stephanie J Bissel; Amy L Hartman; Jonathan P Carney; Katherine J O'Malley; Adebimpe O Obadan; Jefferson Santos; Reagan Walker; Timothy J Sturgeon; Lonnie J Frye; Pauline Maiello; Charles A Scanga; Jennifer D Bowling; Anthea L Bouwer; Parichat A Duangkhae; Clayton A Wiley; JoAnne L Flynn; Jieru Wang; Kelly S Cole; Daniel R Perez; Douglas S Reed; Simon M Barratt-Boyes
Journal:  J Immunol       Date:  2017-01-06       Impact factor: 5.422

8.  Innate immune function and mortality in critically ill children with influenza: a multicenter study.

Authors:  Mark W Hall; Susan M Geyer; Chao-Yu Guo; Angela Panoskaltsis-Mortari; Philippe Jouvet; Jill Ferdinands; David K Shay; Jyotsna Nateri; Kristin Greathouse; Ryan Sullivan; Tram Tran; Shannon Keisling; Adrienne G Randolph
Journal:  Crit Care Med       Date:  2013-01       Impact factor: 7.598

9.  The hemagglutinin protein of highly pathogenic H5N1 influenza viruses overcomes an early block in the replication cycle to promote productive replication in macrophages.

Authors:  Troy D Cline; Erik A Karlsson; Bradley J Seufzer; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

10.  Activation of A1-adenosine receptors promotes leukocyte recruitment to the lung and attenuates acute lung injury in mice infected with influenza A/WSN/33 (H1N1) virus.

Authors:  Famke Aeffner; Parker S Woods; Ian C Davis
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.